Published by
The Street
The Street
By Rob Lenihan Stocks continue their two-day rally after the FDA granted emergency use approval for Pfizer’s breakthrough Covid pill treatment. Stocks were rising Wednesday, bolstered by emergency approval for Pfizer’s (PFE) – Get Pfizer Inc. Report Covid-19 pill and upbeat economic reports. The Dow Jones Industrial Average rose 157 points, or 0.44%, to 35,649, while the S&P 500 advanced 0.53% and the tech-heavy Nasdaq gained 0.54%. The U.S. Food and Drug Administration granted emergency use approval for Pfizer’s Covid-19 treatment pill, the first of its kind to receive clearance in the United…